Organ Donation and Transplantation

Autor: Keith Rigg

Publikováno v: A Medic's Guide to Essential Legal Matters

The organ donation and transplantation sector in the UK has a comprehensive legal and regulatory framework, with some important differences between England, Scotland, Wales, and Northern Ireland. The Human Tissue Act 2004 and the Human Tissue (Scotla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61a7a62f672f04b701ea19fa7d6b94c0
https://doi.org/10.1093/med/9780198749851.003.0007

Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System

Autor: John J. Fung, Dennis Serrano, William H. Marks, Sander Florman, Thomas Peters, J Crippin, Sankaran Sundar, Thomas Gutmann, Abdallah S. Daar, Reynaldo Lesaca, Gary A. Levy, Willem Weimar, Arthur J. Matas, E. T. Ona, Gurch Randhawa, Stephen R. Munn, Glenda Eleanor P. Pamugas, Janet Radcliffe Richards, James D. Eason, Antonio Paraiso, Angeles Tan-Alora, Ajit Huilgol, Alan I. Reed, Romina Danguilan, Ahad Ghods, Alan Norman Langnas, Lewis W. Teperman, Benjamin Hippen, Wulf Gaertner, Frederike Ambagtsheer, Leo Baloloy, Richard N. Fine, Michelle Goodwin, Sally L. Satel, RoseMarie Liquette, Gert van Dijk, Micheal D. H. Asis, Richard B. Freeman, David C. Cronin, Keith Rigg, Walter Land, Robert S. Gaston, David P. T. Price, Hans W. Sollinger, Igal Kam, Edward Cole, Nadey S Hakim, Arlene Lamban, Charles Miller, Nasrollah Ghahramani

Publikováno v: American Journal of Transplantation, 12(2), 306-312. Wiley-Blackwell Publishing Ltd
American Journal of Transplantation, 12(2), 306-312. Wiley

Incentives for organ donation, currently prohibited in most countries, may increase donation and save lives. Discussion of incentives has focused on two areas: (1) whether or not there are ethical principles that justify the current prohibition and (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f4c771197b0c14c1f765e7fe4d294b
https://doi.org/10.1111/j.1600-6143.2011.03881.x

Routine Use of Renal-Dose Dopamine During Living Donor Nephrectomy Has No Beneficial Effect to Either Donor or Recipient

Autor: J. O'Dair, Keith Rigg, M Shehata, L Evans

Publikováno v: Transplantation Proceedings. 37:637-639

Background The use of dopamine as a renoprotective agent in kidney transplantation remains unclear. Some reports suggest that dopamine improves initial graft function and survival, while others have failed to demonstrate a beneficial effect. Our live

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52aea8e8ce5b5729f22a4d6aac9cc9a
https://doi.org/10.1016/j.transproceed.2004.12.211

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in patients with gastrointestinal side effects: case studies

Autor: Keith Rigg, M Shehata, Anita Boswell

Publikováno v: Progress in transplantation (Aliso Viejo, Calif.). 16(2)

Background The potential benefit of the current mycophenolic acid, mycophenolate mofetil, has not yet been fully achieved in clinical transplantation because of its gastrointestinal side effects. Dose splitting, dose reduction, and drug discontinuati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8278467ac4dfc427ce966083031171d
https://pubmed.ncbi.nlm.nih.gov/16789703

The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant

Autor: L Evans, Keith Rigg, A Boswell, M Shehata

Publikováno v: Transplantation proceedings. 37(2)

Introduction The introduction of calcineurin inhibitors (CNIs) in clinical transplantation has resulted in dramatic reduction in acute rejection rate and improvements in short-term allograft survival. However, CNI-induced chronic nephrotoxicity is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ca2eda33a31efad5232fe56971ab121
https://pubmed.ncbi.nlm.nih.gov/15848564